Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Koege – page 84

1 198 clinical trials in Koege, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Koege at a glance
1 198
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 198 trials in Koege

Open in trial search

Lymphoedema

Not recruiting

Study on Tacrolimus Ointment for Reducing Lymphedema in Breast Cancer Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Odense University Hospital

Study of Pariglasgene Brecaparvovec and Prednisolone for Adults with Glycogen Storage Disease Type Ia

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:Ultragenyx Pharmaceutical Inc.

Huntington's disease

Not recruiting

Study on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Tominersen
  • Sponsor:F. Hoffmann-La Roche AG

Uveal melanoma+2

Not recruiting

Study on the Effectiveness and Safety of Belzupacap Sarotalocan for Patients with Small Choroidal Melanoma or Indeterminate Lesions

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Belzupacap Sarotalocan
  • Sponsor:Aura Biosciences Inc.

Neoplasm malignant

Not recruiting

A Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:GEN1047
  • Sponsor:Genmab A/S

Study of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:AstraZeneca AB

Plasma cell myeloma

Not recruiting

Study of Venetoclax, Daratumumab, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Corneal dystrophy

Not recruiting

Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy After Descemetorhexis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ripasudil
  • Sponsor:Kowa Research Institute Inc.

Adenocarcinoma gastric+1

Not recruiting

Study of MK-2870 for Patients with Advanced or Metastatic Stomach Cancer, Comparing Its Effects to a Drug Combination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:Merck Sharp & Dohme LLC

Gene Therapy Study for Severe Coronary Artery Disease Using AdsVEGF-D Delta N Delta C in Patients with Refractory Angina

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Adenovirus Vector Serotype 5 Containing The Vascular Endothelial Growth Factor D Isoform (Preprocessed Short Form)
  • Sponsor:Pohjois-Savon hyvinvointialue

Study of RO7247669, Tiragolumab, and Atezolizumab for Patients with Untreated Advanced Urothelial Cancer Ineligible for Platinum Chemotherapy

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Study of daxdilimab injection for adults with moderate to severe discoid lupus erythematosus

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Daxdilimab
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Koege

What the registry says about research in the country

01 Cardiovascular and Emergency Care Research

Clinical trials in Køge are exploring cardiovascular diseases and acute care, with a focus on improving outcomes for patients with hypotension and shock. These studies are designed to test new treatment approaches that may help stabilize patients faster and reduce the need for intensive care.

  • Early treatment strategies for low blood pressure and shock
  • New approaches to reduce cardiovascular risk
  • Supportive care for emergency department patients

The research reflects a strong interest in faster, more effective care for serious circulatory conditions.

02 Diabetes and Metabolic Disease Studies

Several trials are centered on type 1 diabetes and related nutritional and metabolic diseases, including efforts to lower long-term cardiovascular complications. The research is aimed at testing whether more intensive care strategies and new treatment options can improve health outcomes for people living with diabetes.

  • Intensified care for people with type 1 diabetes at high cardiovascular risk
  • Evaluating protective treatment options for heart-related complications
  • Improving long-term disease control in diabetes

These studies combine prevention and treatment research to support better chronic disease management.

03 Bone, Joint, and Musculoskeletal Research

Research in musculoskeletal diseases includes trials for diabetic acute Charcot foot, a serious complication that can affect mobility and bone health. The main purpose is to evaluate whether a new treatment approach can improve healing and protect patients from further damage.

  • Treatment options for acute Charcot foot in diabetes
  • Restoring function and reducing complications
  • Clinical outcomes in diabetic foot care

This area of research is especially important for preserving movement and quality of life.

04 Ear, Nose, and Throat Research

Trials in otorhinolaryngologic diseases are focusing on chronic rhinosinusitis with nasal polyps, also known as CRSwNP. These studies are assessing whether patients who have responded well to biologic treatment can safely reduce or stop therapy without symptoms returning.

  • Long-term management of nasal polyps
  • Testing the durability of biologic treatment responses
  • Reducing treatment burden while maintaining disease control

This research aims to make care more tailored for people with persistent sinus disease.

05 Digestive System and Gastrointestinal Research

Clinical trials in digestive system diseases are investigating bile acid diarrhoea, with the goal of improving stool consistency and overall symptom control. The studies are evaluating whether a new tablet formulation can provide meaningful relief compared with placebo.

  • Symptom control in bile acid diarrhoea
  • Testing a new treatment for better bowel function
  • Improving quality of life for patients with chronic diarrhoea

These trials focus on practical treatment benefits that matter in everyday care.

06 Hormonal and Chronic Disease Care

Trials linked to hormonal diseases are also part of the research landscape, especially through studies involving diabetes-related complications and broader chronic disease management. The aim is to better understand how targeted therapies can support patients with complex, long-term conditions.

  • Chronic disease control in people with endocrine-related conditions
  • Supporting safer treatment strategies
  • Exploring therapies that may improve long-term outcomes

In Køge, this area connects closely with ongoing diabetes research and prevention-focused care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.